166 related articles for article (PubMed ID: 22661699)
1. Expression of CD30 in patients with acute graft-versus-host disease.
Chen YB; McDonough S; Hasserjian R; Chen H; Coughlin E; Illiano C; Park IS; Jagasia M; Spitzer TR; Cutler CS; Soiffer RJ; Ritz J
Blood; 2012 Jul; 120(3):691-6. PubMed ID: 22661699
[TBL] [Abstract][Full Text] [Related]
2. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
3. Immune cell subset counts associated with graft-versus-host disease.
Podgorny PJ; Liu Y; Dharmani-Khan P; Pratt LM; Jamani K; Luider J; Auer-Grzesiak I; Mansoor A; Williamson TS; Ugarte-Torres A; Hoegh-Petersen M; Stewart DA; Daly A; Khan FM; Russell JA; Storek J
Biol Blood Marrow Transplant; 2014 Apr; 20(4):450-62. PubMed ID: 24406506
[TBL] [Abstract][Full Text] [Related]
4. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
5. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
[TBL] [Abstract][Full Text] [Related]
6. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
[TBL] [Abstract][Full Text] [Related]
7. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
8. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.
Zeiser R; Nguyen VH; Hou JZ; Beilhack A; Zambricki E; Buess M; Contag CH; Negrin RS
Blood; 2007 Mar; 109(5):2225-33. PubMed ID: 17068147
[TBL] [Abstract][Full Text] [Related]
9. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
[TBL] [Abstract][Full Text] [Related]
10. Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.
Pastore D; Delia M; Mestice A; Perrone T; Carluccio P; Gaudio F; Giordano A; Rossi AR; Ricco A; Leo M; Liso V; Specchia G
Biol Blood Marrow Transplant; 2011 Apr; 17(4):550-7. PubMed ID: 20457268
[TBL] [Abstract][Full Text] [Related]
11. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
12. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
Front Immunol; 2020; 11():593321. PubMed ID: 33584657
[TBL] [Abstract][Full Text] [Related]
13. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
14. CD4
Alhaj Hussen K; Michonneau D; Biajoux V; Keita S; Dubouchet L; Nelson E; Setterblad N; Le Buanec H; Bouaziz JD; Guimiot F; Socié G; Canque B
Front Immunol; 2020; 11():579776. PubMed ID: 33329550
[TBL] [Abstract][Full Text] [Related]
15. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
16. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Chen YB; Kim HT; McDonough S; Odze RD; Yao X; Lazo-Kallanian S; Spitzer TR; Soiffer R; Antin JH; Ritz J
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1066-76. PubMed ID: 19660719
[TBL] [Abstract][Full Text] [Related]
18. Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.
Chen YB; McDonough S; Chen H; Kennedy J; Illiano C; Attar EC; Ballen KK; Dey BR; McAfee SL; Jagasia M; Soiffer R; Spitzer TR; Ritz J
Bone Marrow Transplant; 2013 Apr; 48(4):598-603. PubMed ID: 23042495
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease.
Chen YB; Perales MA; Li S; Kempner M; Reynolds C; Brown J; Efebera YA; Devine SM; El-Jawahri A; McAfee SL; Spitzer TR; Soiffer RJ; Ritz J; Cutler C
Blood; 2017 Jun; 129(24):3256-3261. PubMed ID: 28473406
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
